Key Concepts:
- The most common anti-depressant prescribed globally is SSRI. Fluoxetine is one of the common prescribed SSRI
- Half life of fluoxetine is approximately 4-6 hours
- Common side effects of Fluoxetine are related to CNS, GI, and sexual dysfunction.
- There is a risk of serotonin syndrome when combined with MAOIs, triptans, or linezolid.
- Preferred for patients with fatigue due to its activating effect.
For international pharmacists who wish to become a registered pharmacist in Australia, they have to successfully clear the OPRA Exam (Overseas Pharmacist Readiness Assessment). In the OPRA exam, the test contains questions which revolve around the core topics of pharmacy. There are many medications which are frequently prescribed globally. A skillful pharmacist must have clear knowledge about these and that's why these competitive exams have questions from those topics.
Fluoxetine is one of the most commonly prescribed antidepressants and is widely tested in the OPRA (Overseas Pharmacist Readiness Assessment) exam. To work in an advanced healthcare sector like that in Australia, a pharmacist who knows the adverse effects, monitoring parameters, and patient counselling points is essential for safe clinical practice. This guide covers everything you need to know about the adverse effects of fluoxetine, along with key concepts, FAQs, and study tips to help you ace your OPRA exam.
What is Fluoxetine?
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant. Fluoxetine inhibits the uptake of serotonin by nerve cells (neurons) and helps people with depression, panic, anxiety, or obsessive-compulsive symptoms.
- Major depressive disorder (MDD)
- Obsessive-compulsive disorder (OCD)
- Bulimia nervosa
- Panic disorder
- Premenstrual dysphoric disorder (PMDD)
Fluoxetine will increase the serotonin levels in the human brain. Serotonin is responsible for regulating mood and reducing depressive symptoms.
Key Adverse Effects of Fluoxetine
| System | Common Adverse Effects | Serious Adverse Effects |
|---|---|---|
| Central Nervous System | Insomnia, headache, anxiety, nervousness, tremor | Seizures, mania/hypomania activation, serotonin syndrome |
| Gastrointestinal | Nausea, diarrhea, dry mouth, anorexia | GI bleeding |
| Sexual | Decreased libido, delayed ejaculation, anorgasmia | Persistent sexual dysfunction |
| Metabolic / Weight | Weight loss (initial), appetite suppression | Long-term weight gain possible |
| Dermatological | Sweating, rash | Stevens-Johnson syndrome (rare) |
| Cardiac | Palpitations | QT prolongation (rare, high dose/interaction) |
| Others | Fatigue, yawning | Hyponatremia (SIADH), especially in elderly |
Monitoring Parameters
- Monitor for suicidal temptations, especially when the therapy has started
- There is a risk of hyponatremia, Check sodium levels in elderly patients for safety
- Fluoxetine has drug interaction with CYP2D6 interactions (e.g., TCAs, antipsychotics).
- Fluoxetine has a long half-life, but discontinuation symptoms can still occur
Patient Counselling Points
- Fluoxetine should be taken in the morning. If taken at night, it can cause insomnia.
- It shows effects within 4–6 weeks to show.
- This medication should not be stopped immediately or abruptly.
- symptoms like confusion, sweating, tremors, or fever is common in patients who take the fluoxetine
- Patients should Avoid alcohol while being on antidepressant medication
Conclusion
One popular SSRI with a well-known safety record is fluoxetine. Fluoxetine is always having serious side effects such as serotonin syndrome, seizures, or QT prolongation that require monitoring.
However, the majority of side effects are minor and temporary. Patients should pay attention to the drug interactions, side effects, mechanism of action, and counseling points when preparing for competitive exams like the OPRA exam.